---
title: "NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294971583.md"
description: "Expedition Therapeutics secured $115 million in Series B funding, with its CEO joining NYSE Live to discuss the dosing of first patients in the Phase 2 trial for EXPD-101, a COPD treatment. Meanwhile, Zeta Global reported its 20th consecutive 'beat-and-raise' quarter and achieved the 'Rule of 64.' Market indices reached new highs amid Middle East deal hopes."
datetime: "2026-08-05T12:55:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294971583.md)
  - [en](https://longbridge.com/en/news/294971583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294971583.md)
generator: "portal-rs"
---

# NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

*NYSE issues a pre-market daily advisory direct from the trading floor.*

NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.

**Ashley Mastronardi delivers the pre-market update on August 5th**

-   The Dow Jones Industrial Average and S&P 500 will look to build off fresh records on hopes of a deal in the Middle East.
    -   The Dow surpassed 54,000 for the first time ever.
    -   The S&P 500 clinched its first-ever close above 7,700.
-   Expedition Therapeutics Founder & CEO Yi Larson will join NYSE Live following her firm's latest funding round.
    -   The company says the first patients have been dosed in its Phase 2 clinical trial for EXPD-101, a next-gen treatment for COPD.
-   Zeta Global () CEO David Steinberg will join NYSE Live to deliver the biggest takeaways from the company's Q2 earnings report.
    -   The firm says it posted its 20th straight 'beat-and-raise' quarter and achieved the 'Rule of 64.'

**Opening Bell**AB InBev () rings the NYSE Opening Bell

**Closing Bell**

Blend () celebrates its 5th anniversary of listing

**For market insights, IPO activity, and today's opening bell, download the NYSE TV App:** **TV.NYSE.com**

### Related Stocks

- [ZETA.US](https://longbridge.com/en/quote/ZETA.US.md)
- [ZETX.US](https://longbridge.com/en/quote/ZETX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [BUD.US](https://longbridge.com/en/quote/BUD.US.md)
- [BLND.US](https://longbridge.com/en/quote/BLND.US.md)

## Related News & Research

- [Silynxcom (NYSE American: SYNX) Is ‘One to Watch’](https://longbridge.com/en/news/297213654.md)
- [Beyond Air says FDA grants Breakthrough Device tag for LungFit GO in NTM lung disease](https://longbridge.com/en/news/297513609.md)
- [NYSE opens Texas headquarters in Dallas](https://longbridge.com/en/news/297345649.md)
- [Liquidia launches Phase 3 Re-Spire trial of L606 inhaled treprostinil in PH-ILD](https://longbridge.com/en/news/297786781.md)
- [Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update](https://longbridge.com/en/news/297790109.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**